Filter
1501
Filtered Results: 1501
Text search:
Smith,
E.M.
Featured
Recommendations
114
New Publications
228
Language
Document type
No document type
741
Studies & Reports
350
Guidelines
250
Manuals
83
Strategic & Response Plan
25
Fact sheets
24
Training Material
17
Situation Updates
5
Infographics
4
Resource Platforms
2
Countries / Regions
Global
61
India
40
Western and Central Europe
34
South Africa
31
Russia
26
Latin America and the Carribbean
22
Brazil
21
Africa
18
Sierra Leone
15
Malawi
14
Mozambique
14
Kenya
13
Eastern Europe
13
Uganda
12
Liberia
11
Bangladesh
11
Ukraine
11
Germany
10
Syria
10
Argentina
10
Myanmar / Burma
10
Nigeria
9
Ethiopia
9
Philippines
8
Tanzania
8
Guinea
7
Burkina Faso
7
Senegal
7
Congo, Democratic Republic of
7
Cameroon
7
Ghana
7
Nepal
7
Zambia
7
Middle East and North Africa
7
South–East Asia Region
7
Paraguay
7
Venezuela
7
Zimbabwe
6
Indonesia
6
South Sudan
5
Spain
5
USA
4
Pakistan
4
Lesotho
4
Yemen
4
West and Central Africa
4
Asia
4
Afghanistan
3
Benin
3
Botswana
3
Chile
3
East and Southern Africa
3
Eastern Europe and Central Asia
3
Southern Africa
3
Vietnam
3
Cambodia
2
Thailand
2
China
2
Rwanda
2
Sudan
2
Peru
2
Colombia
2
Ecuador
2
Angola
2
Madagascar
2
Georgia
2
North America
2
United Kingdom
2
Portugal
2
Mali
1
Guinea-Bissau
1
Saudi Arabia
1
Haiti
1
Somalia
1
Chad
1
Singapore
1
Namibia
1
North Macedonia
1
Burundi
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Western Pacific Region
1
Italy
1
Armenia
1
Canada
1
Romania
1
Kyrgyzstan
1
Uruguay
1
Belgium
1
Belarus
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
330
Clinical Guidelines
133
Public Health
103
Women & Child Health
71
Key Resources
39
Capacity Building
18
Pharmacy & Technologies
9
Toolboxes
Mental Health
221
COVID-19
175
HIV
125
Planetary Health
119
TB
107
Disability
74
NCDs
52
Caregiver
48
AMR
40
NTDs
40
Ebola
35
Global Health Education
35
Rapid Response
26
Conflict
25
Pharmacy
21
Health Financing Toolbox
18
Natural Hazards
13
Specific Hazards
11
Polio
9
Refugee
9
Zika
9
Social Ethics
7
Cholera
4
Health Financing
1
UNAIDS report on the global AIDS epidemic shows that 2020 targets will not be met because of deeply unequal success; COVID-19 risks blowing HIV progress way off course. Missed targets have resulted in 3.5 million more HIV infections and 820 000 more AIDS-related deaths since 2015 than if the world w...
WHO‘s Global Strategy to Accelerate the Elimination of Cervical Cancer, launched today, outlines three key steps: vaccination, screening and treatment. Successful implementation of all three could reduce more than 40% of new cases of the disease and 5 million related deaths by 2050.
Despite being a curable and preventable disease, tuberculosis (TB) remains as one of the major challenges for health systems, globally. Every year, TB affects more than 10 million people and kills more than 1.4 million people. WHO’s Digital Health for the End TB Strategy – an Agenda for Action o...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
This paper reviews the effects of vertical responses to COVID-19 on health systems, services, and people’s access to and use of them in LMICs, where historic and ongoing under-investments heighten vulnerability to a multiplicity of health threats. We use the term ‘vertical response’ to describ...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
BMJ Global Health2020;5:e001980. doi:10.1136/bmjgh-2019-00198
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
Änderung gegenüber der Version vom 26.1.2021: Aktualisierung der Informationen über monoklonale Antikörper und Rekonvaleszentenplasma
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
The Quality Criteria for Health National Adaptation Plans (HNAPs) presents examples of good practice in HNAP development to assist countries in developing a comprehensive, feasible and implementable plan. The criteria are also intended to guide countries in setting the foundation for a long-term ite...
Au cours de la dernière décennie, les données de séquençage génétique des agents pathogènes ont gagné en importance et contribuent désormais de façon déterminante à la détection et à la maîtrise des flambées de maladies infectieuses, en facilitant la mise au point de ...
En el último decenio, los datos de las secuencias genéticas de los patógenos han adquirido un papel crucial en la detección y el manejo de los brotes de enfermedades infecciosas, contribuyendo al desarrollo de pruebas diagnósticas, medicamentos y vacunas y orientando la respuesta sanitaria.
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
Workplaces outside of healthcare facilities can be also settings for transmission of COVID-19. Outbreaks of COVID-19 has been reported in various types of workplaces and job categories.
All workers should be protected from acquiring COVID-19 because of their work. The prevention of COVID-19 in ...
orientaciones provisionales, primera publicación: 24 de mayo de 2021, actualización: 21 de octubre de 2021, actualización: 15 de marzo de 2022
